Value Sense
HUM
Humana Inc. (HUM)
Last Price$261.5(3.3%)
Market Cap$31.5B
LTM P/E
26.1x
EPS growth
18.9%
PEGY
1.3x
Peter Lynch Fair Value
$202.5
Overvalued (Peter Lynch formula)
(22.6%)
Stock quality
6/10
Good
HUM
is 205.0% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

HUM Peter Lynch Fair Value

Peter Lynch Fair Value Assumptions

as of Mar 10, 2025
LTM P/E
26.1x
EPS growth
18.9%
Dividend Yield
1.4%
PEGY
1.3x
Last share price
$261.5
Peter Lynch Fair Value
$202.5
22.6% overvalued

Peter Lynch Fair Value Calculation

PEGY
1.3x
=
LTM P/E
26.1x
/
(
EPS growth
18.86%
+
Dividend yield
1.37%
)
Peter Lynch
Fair Value
$202.5
=
Last share price
$261.5
/
PEGY
1.3x

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

HUM EPS growth & Dividend Yield

Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
EPS growth
Dividend Yield

HUM vs Peer Set: Peter Lynch Fair Value Comparison

General

PETER LYNCH FAIR VALUE

Financial metrics

Company name

Undervaluation / Overvaluation

Revenue growth

EBITDA margin

Net Income margin

Humana Inc. logo
Humana Inc.HUM
(22.6%)
10.7%
(50.1%)
1.0%
Median Peer Set
8.4%
(11.9%)
2.0%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
60.6%
8.9%
(35.7%)
3.6%
Elevance Health Inc. logo
Elevance Health Inc.ELV
75.3%
3.2%
(0.0%)
3.4%
Cigna Corporation logo
Cigna CorporationCI
40.5%
8.4%
(18.9%)
2.6%
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
34.5%
19.3%
9.2%
2.9%
CVS Health Corporation logo
CVS Health CorporationCVS
131.4%
4.2%
(43.6%)
1.2%
Centene Corporation logo
Centene CorporationCNC
39.4%
5.9%
27.4%
2.0%
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
52.0%
56.5%
N/A
0.3%
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
(26.9%)
27.2%
(4.8%)
(8.1%)
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
1.0%
(41.5%)
(31.3%)
(10.5%)

Explore more intrinsic value tools hub for HUM

Margin of safety
Ben Graham Fair Value
Earnings growth model
Discount rate
Peter Lynch charts
Reverse DCF
Earnings Power Value
Intrinsic Value
DCF value calculator
Relative Value

FAQ

What is Humana Inc. fair value by Peter Lynch formula?

As of Mar 03, 2025, Humana Inc.'s fair value using the Peter Lynch formula is $202.5 per share. The current price of $261.5 suggests Humana Inc. may be overvalued by this metric.

What is Humana Inc. Price to Earnings (P/E) ratio?

As of Mar 03, 2025, Humana Inc.'s P/E ratio is 26.1x. This is calculated by dividing the current share price of $261.5 by the Earnings per Share (EPS) for the trailing twelve months, which is $10.0. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.

What is Humana Inc. earnings per share (EPS)?

Humana Inc. earnings per share (EPS) for the twelve months ending Mar 03, 2025, was $10.0, a 18.9% growth year-over-year.